Mount Nebo Capital Partners
4
4
4.00
- Stages of investment
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
- Geo focus
- Check size
- 250K — 50M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Rounds per year
- 4.00
- Investments by industry
- E-Commerce (2)
- Life Science (1)
- Biopharma (1)
- Biotechnology (1)
- Software (1) Show 3 more
- Investments by region
- United States (3)
- Germany (1)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 2
- Avg. valuation at time of investment
- 1M
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Front Finance | 28 Jun 2023 | Financial Services, FinTech | Seed | United States, California, San Francisco |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| HDAX Therapeutics | Sep 5, 2024 | Cardiometabolic Diseases, Molecular Recognition Technology, Neurological Diseases, Therapeutics | Early stage | 3200000 USD | |
| NeuReality | Mar 19, 2024 | AI, AI Inference, Data Center Infrastructure | - | 20000000 USD | |
| VerImmune | Jul 29, 2022 | Biotechnology, Cancer Therapy, Virus-inspired Particle Platform | Early stage | 2500000 USD |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.